Remifentanil hydrochloride and Magnesium sulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Remifentanil hydrochloride (remifentanil hydrochloride) and Magnesium sulfate (magnesium sulfate). Common drug interactions include neutrophil count decreased among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Remifentanil hydrochloride and Magnesium sulfate. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Remifentanil hydrochloride?

Remifentanil hydrochloride has active ingredients of remifentanil hydrochloride. eHealthMe is studying from 1,327 Remifentanil hydrochloride users. Check the latest studies of Remifentanil hydrochloride.

What is Magnesium sulfate?

Magnesium sulfate has active ingredients of magnesium sulfate. It is often used in migraine. eHealthMe is studying from 18,024 Magnesium sulfate users. Check the latest studies of Magnesium sulfate.

On Jul, 16, 2026

27 people who take Remifentanil hydrochloride and Magnesium sulfate together, and have interactions are studied.

Remifentanil hydrochloride and Magnesium sulfate drug interactions.

What are the common drug interactions of Remifentanil Hydrochloride and Magnesium Sulfate, by gender? *:

female:

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Cardiac failure acute
Drug ineffective
Maternal exposure during delivery (use of substance during pregnancy)
Overdose
Premature baby
Septic shock (shock due to blood infection)
Acidosis (build-up of carbon dioxide in the blood)
Anaesthetic complication
Anaphylactic reaction (serious allergic reaction)

male:

Pneumonia
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)
Abdominal pain
Clostridial infection (infectious conditions by clostridium bacteria)
Conjunctivitis (pink eye)
Depressed level of consciousness
Diarrhoea
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Febrile neutropenia (fever with reduced white blood cells)

What are the common drug interactions of Remifentanil Hydrochloride and Magnesium Sulfate, by age (0-1 to 60+)? *:

0-1:

Abdominal pain
Clostridial infection (infectious conditions by clostridium bacteria)
Conjunctivitis (pink eye)
Diarrhoea
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Febrile neutropenia (fever with reduced white blood cells)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pain
Penile ulceration

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Acidosis (build-up of carbon dioxide in the blood)
Anaphylactic reaction (serious allergic reaction)
Blood ph decreased
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Dermatitis allergic (inflammation of the skin due allergic reaction)
Drug ineffective
Hypercapnia (too much smoke)
Hypertensive crisis
Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body)
Maternal exposure during delivery (use of substance during pregnancy)

40-49:

Anaesthetic complication
Drug exposure during pregnancy
Neuromuscular block prolonged
Placenta praevia (a condition that occurs during pregnancy when the placenta is abnormally placed, and partially or totally covers the cervix)
Premature baby
Threatened labour (premature labour is the onset of labour between 24 and 37 weeks of pregnancy)

50-59:

n/a

60+:

Pneumonia
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Pulmonary alveolar haemorrhage (acute bleeding)
Pyrexia (fever)
Respiratory failure (inadequate gas exchange by the respiratory system)
Septic shock (shock due to blood infection)
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)
Depressed level of consciousness
Drug ineffective
Glossoptosis

What are the existing conditions these people have? *

Sedation: 12 people, 44.44%
Haemostasis (stopping of bleeding): 8 people, 29.63%
Urination - Excessive Volume: 8 people, 29.63%
Asthma: 6 people, 22.22%
Blood Potassium Decreased: 5 people, 18.52%
Oesophageal Squamous Cell Carcinoma (cancer that begins in flat cells lining the oesophagus): 5 people, 18.52%
High Blood Pressure: 5 people, 18.52%
Productive Cough: 4 people, 14.81%
Cardiac Disorder: 4 people, 14.81%
Arrhythmias (irregular heartbeat): 4 people, 14.81%

* Approximation only. Some reports may have incomplete information.

Do you take Remifentanil hydrochloride and Magnesium sulfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously